Skip to main content
Fig. 2 | Journal of Experimental & Clinical Cancer Research

Fig. 2

From: The immune microenvironment of HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma: a multiparametric quantitative and spatial analysis unveils a rationale to target treatment-naïve tumors with immune checkpoint inhibitors

Fig. 2

Immune signatures of TIME impact on survival of OPSCC patients. A-C Kaplan-Meier survival curves for disease-free survival according to high/low gene expression-based cell types and pathways profiling (classification based on median expression as cut-off), in (A) all OPSCC patients (n = 39), (B) HPV-positive (n = 24) and (C) HPV-negative patients (n = 15). Log-rank statistics were performed to determine significance; p values, hazard ratios (HR) and 95% confidence intervals (CI) are reported in each graph

Back to article page